Clinical study on long-term overall survival of advanced non-small-cell lung cancer patients treated with Chinese medicine and western medicine

被引：0
|
作者：
Yan-zhi Chen
Xiao-bing Feng
Zhan-dong Li
Wen-xian Zheng
Hong Sun
Ping-ping Li
机构：
[1] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integrated Traditional Chinese and Western Medicine
来源：
Chinese Journal of Integrative Medicine | 2014年 / 20卷
关键词：
non-small cell lung cancer; long-term overall survival; prognosis; Chinese medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：179 / 183
页数：4
相关论文
共 50 条
  • [21] Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy
    Xu, Zhen Ye
    Jin, Chang Juan
    Zhou, Cai Cun
    Wang, Zhong Qi
    Zhou, Wei Dong
    Deng, Hai Bin
    Zhang, Ming
    Su, Wan
    Cai, Xiao Yue
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (07) : 1117 - 1122
  • [22] Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy
    Zhen Ye Xu
    Chang Juan Jin
    Cai Cun Zhou
    Zhong Qi Wang
    Wei Dong Zhou
    Hai Bin Deng
    Ming Zhang
    Wan Su
    Xiao Yue Cai
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1117 - 1122
  • [23] Overall survival should be the primary endpoint in clinical trials for advanced non-small-cell lung cancer
    Cheema, P. K.
    Burkes, R. L.
    CURRENT ONCOLOGY, 2013, 20 (02) : E150 - E160
  • [24] Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery
    Flannery, Todd W.
    Suntharalingam, Mohan
    Regine, William F.
    Chin, Lawrence S.
    Krasna, Mark J.
    Shehata, Michael K.
    Edelman, Martin J.
    Kremer, Marnie
    Patchell, Roy A.
    Kwok, Young
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : 19 - 23
  • [25] IDENTIFICATION AND CHARACTERIZATION OF LONG TERM SURVIVAL POPULATION IN NON-SMALL-CELL LUNG CANCER PATIENTS TREATED WITH IMMUNOTHERAPIES
    Luaces, P.
    Sanchez, L.
    Viada, C.
    Rodriguez, P. C.
    Alvarez, M.
    Fonte, C.
    Muchene, L.
    Shkedy, S.
    Lage, A.
    VALUE IN HEALTH, 2015, 18 (03) : A193 - A193
  • [26] Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study
    von Pawel, J.
    Bordoni, R.
    Satouchi, M.
    Fehrenbacher, L.
    Cobo, M.
    Han, J. Y.
    Hida, T.
    Moro-Sibilot, D.
    Conkling, P.
    Gandara, D. R.
    Rittmeyer, A.
    Gandhi, M.
    Yu, W.
    Matheny, C.
    Patel, H.
    Sandler, A.
    Ballinger, M.
    Kowanetz, M.
    Park, K.
    EUROPEAN JOURNAL OF CANCER, 2019, 107 : 124 - 132
  • [27] Effect of integrated Chinese medical treatment on the survival time of patients with advanced non-small-cell lung cancer: a clinical study
    刘苓霜
    China Medical Abstracts (Internal Medicine), 2014, 31 (03) : 135 - 135
  • [28] Long-Term Survival of Patients with Metastatic Non-Small-Cell Lung Cancer over Five Decades
    Bar, Jair
    Urban, Damien
    Amit, Uri
    Appel, Sarit
    Onn, Amir
    Margalit, Ofer
    Beller, Tamar
    Kuznetsov, Teodor
    Lawrence, Yaacov
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [29] Clinical factors predictive of long-term survival in advanced non-small cell lung cancer
    Van Damme, V.
    Govaerts, E.
    Nackaerts, K.
    Dooms, C.
    Wauters, I.
    Vansteenkiste, J.
    LUNG CANCER, 2013, 79 (01) : 73 - 76
  • [30] Personalized medicine for non-small-cell lung cancer
    Mok, Tony S.
    Zhou, Qing
    Leung, Linda
    Loong, Herbert H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (10) : 1601 - 1611
12345